AddLife AB (publ) Asset Resilience Ratio
AddLife AB (publ) asset resilience ratio. AddLife AB (publ) (ALIF-B) has an Asset Resilience Ratio of 6.40% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does AddLife AB (publ) carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of AddLife AB (publ) (2016–2025)
Asset resilience ratio of AddLife AB (publ) from 2016 to 2025. This chart shows how AddLife AB (publ)'s Asset Resilience Ratio has changed over time. See AddLife AB (publ) free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down AddLife AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ALIF-B asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr813.00 Million | 6.4% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr813.00 Million | 6.40% |
Asset Resilience Insights
- Limited Liquidity: AddLife AB (publ) maintains only 6.40% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
AddLife AB (publ) Industry Peers by Asset Resilience Ratio
Compare AddLife AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101 |
Medical Instruments & Supplies | 47.21% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
St.Shine Optical Co Ltd
TWO:1565 |
Medical Instruments & Supplies | 1.28% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
AddLife AB (publ) Asset Resilience Ratio by Year (2016–2025)
AddLife AB (publ) asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for AddLife AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.40% | Skr813.00 Million ≈ $87.49 Million |
Skr12.71 Billion ≈ $1.37 Billion |
+3.86pp |
| 2024-12-31 | 2.54% | Skr331.00 Million ≈ $35.62 Million |
Skr13.05 Billion ≈ $1.40 Billion |
-0.20pp |
| 2023-12-31 | 2.74% | Skr349.00 Million ≈ $37.56 Million |
Skr12.74 Billion ≈ $1.37 Billion |
+0.58pp |
| 2022-12-31 | 2.16% | Skr282.00 Million ≈ $30.35 Million |
Skr13.06 Billion ≈ $1.41 Billion |
-0.97pp |
| 2021-12-31 | 3.13% | Skr331.70 Million ≈ $35.70 Million |
Skr10.60 Billion ≈ $1.14 Billion |
-1.83pp |
| 2020-12-31 | 4.96% | Skr205.80 Million ≈ $22.15 Million |
Skr4.15 Billion ≈ $446.56 Million |
+2.05pp |
| 2019-12-31 | 2.91% | Skr95.40 Million ≈ $10.27 Million |
Skr3.27 Billion ≈ $352.38 Million |
+0.80pp |
| 2018-12-31 | 2.11% | Skr56.30 Million ≈ $6.06 Million |
Skr2.67 Billion ≈ $287.10 Million |
+1.82pp |
| 2017-12-31 | 0.29% | Skr5.40 Million ≈ $581.13K |
Skr1.89 Billion ≈ $203.53 Million |
-0.65pp |
| 2016-12-31 | 0.93% | Skr14.70 Million ≈ $1.58 Million |
Skr1.58 Billion ≈ $169.68 Million |
-- |
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical resear… Read more